---
title: "TSHA.US (TSHA.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/TSHA.US/news.md"
symbol: "TSHA.US"
name: "TSHA.US"
parent: "https://longbridge.com/en/quote/TSHA.US.md"
datetime: "2026-05-21T20:58:44.168Z"
locales:
  - [en](https://longbridge.com/en/quote/TSHA.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/TSHA.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/TSHA.US/news.md)
---

# TSHA.US (TSHA.US) — Related News

### [Taysha Gene Therapies Ramps Up Ahead of TSHA-102 BLA](https://longbridge.com/en/news/285857474.md)
*2026-05-11T00:11:07.000Z*
> Taysha Gene Therapies, Inc. (TSHA) held its Q1 earnings call, highlighting strong clinical momentum for its Rett syndrom

### [Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Given Average Recommendation of "Buy" by Brokerages](https://longbridge.com/en/news/285834702.md)
*2026-05-10T08:33:09.000Z*
> Taysha Gene Therapies, Inc. (NASDAQ:TSHA) has received an average "Buy" recommendation from thirteen analysts. One analy

### [Taysha Gene Therapies Q1 Earnings Call Highlights](https://longbridge.com/en/news/285502614.md)
*2026-05-07T07:24:28.000Z*
> Taysha Gene Therapies (NASDAQ:TSHA) reported regulatory progress and ongoing clinical enrollment for its Rett syndrome g

### [Chardan Capital Remains a Buy on Taysha Gene Therapies (TSHA)](https://longbridge.com/en/news/285422995.md)
*2026-05-06T18:55:33.000Z*
> Chardan Capital's Geulah Livshits has reiterated a Buy rating on Taysha Gene Therapies (TSHA) with a price target of $12

### [Taysha Gene Therapies | 8-K: FY2026 Q1 Revenue: USD 0](https://longbridge.com/en/news/285375211.md)
*2026-05-06T12:15:25.000Z*
### [Taysha Gene Therapies (TSHA) to Release Earnings on Wednesday](https://longbridge.com/en/news/284957833.md)
*2026-05-02T06:42:16.000Z*
> Taysha Gene Therapies (NASDAQ:TSHA) is set to release its Q1 2026 earnings on May 6, with analysts predicting a loss of 

### [Taysha Gene Therapies to Release First Quarter 2026 Financial Results and Host Conference Call and Webcast on May 6](https://longbridge.com/en/news/284570150.md)
*2026-04-29T12:02:04.000Z*
> Taysha Gene Therapies, a biotech company trading as TSHA on Nasdaq, will be releasing their financial results for the fi